Skip to main content
Home
Member Login
Join Our Contact Registry
RDCRN logo

Header Social Media

  • Our Research
    • Research Studies
    • Clinical Sites
    • CEGIR Publications
    • CEGIR-Related Publications
    • Diseases Studied
  • Patients and Families
    • Patient Advocacy Groups
    • Resources for Patients and Families
    • Frequently Asked Questions
    • Glossary
  • Researchers and Clinicians
    • Resources For Researchers and Clinicians
    • Collaborate With Us
    • Disorder Definitions
    • Funding Opportunities
    • Endoscopy Best Practices
    • Treatment Guidelines
  • CEGIR Awards
    • Funding Opportunities
    • Pilot and Feasibility Grants
    • Scholar Awards
    • Meet Our CEGIR Scholars
    • Previous Trainees/Scholars
  • News and Events
    • Events
    • Latest News
  • About Us
    • Our Consortium
    • Meet Our Team
    • Goals, Mission & Vision
    • Contact Us
An NIH-Funded Rare Diseases Clinical Research Network Consortium

Latest News

Rare Research Report: July 2026

Each month, we share summaries of recent Rare Diseases Clinical Research Network grant-funded publications. Catch up on RDCRN research for July 2026.

Read More
Rare Research Report logo

Learn About CEGIR in Overview Video

November 4 2021

Read More
Consortium of Eosinophilic Gastrointestinal Disease Researchers

RDCRN Research Roundup: November 2021

November 1 2021

Read More
RDCRN

Researchers Provide Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals

August 17 2021

Read More
Image
A screenshot from the JAMA Network article, Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals

A Rare Disease Day Update: RDCRN Survey on Impacts of COVID-19

July 23 2021

Read More
screenshot of the rare disease update video

RDCRN Announces New 2021 Network Steering Committee Leadership

February 11 2021

Read More
Headshots of Jennifer Puck, MD, Andrea Gropman, MD, and Marc Rothenberg, MD, PhD

Scientist Spotlight: Marc Rothenberg Leads Eosinophilic Collaboration and Research to New Discoveries

January 14 2021

Read More
Marc Rothenberg, MD, PhD

The CURED Difference

June 25 2020

Read More
The Campaign Urging Research for Eosinophilic Disease (CURED) logo appears over a geometric design featuring fuchsia, teal, and purple triangles.

APFED & CEGIR Announce Recipient for 2020 Co‐funded Pilot Grant Award

June 4 2020

Read More
Headshot of Paneez Khoury, MD, MHSc
  • Load More

Footer

  • Web Policies
  • Rare Diseases Clinical Research Network
  • Genetic and Rare Diseases Information Center
  • Members Login
  • Contact Us

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). CEGIR is funded under grant number U54AI117804 as a collaboration between NCATS and the National Institute of Allergy and Infectious Diseases (NIAID). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818. The content of this website is solely the responsibility of the CEGIR administrative coordinating center at Cincinnati Children’s Hospital Medical Center and does not necessarily represent the official views of the NIH.

social media